Skip to main content

Table 3 Univariate and multivariate analysis of the associations between IDDVT and baseline characteristics in training cohort

From: Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study

Variables Univariate analysis Multivariate analysis
β coefficient OR 95% CI P-value β coefficient OR 95% CI P-value
Demography parameters         
Age (years) 0.047 1.048 1.025–1.072 < 0.001 0.028 1.028 1.003–1.054 0.029
Gender (female) 0.753 2.124 1.342–3.364 0.001 0.638 1.893 1.142–3.137 0.013
Clinical parameters         
Lower limb paralysis −1.744 2.910 1.826–4.639 < 0.001 0.987 2.682 1.623–4.434 < 0.001
Current pneumonia 1.209 3.349 2.002–5.601 < 0.001 0.846 2.331 1.321–4.111 0.003
Atrial fibrillation 1.142 3.132 1.861–5.270 < 0.001 0.989 2.689 1.525–4.743 0.001
Arterial hypertension −0.132 0.876 0.521–1.476 0.620     
Diabetes mellitus 0.138 1.148 0.717–1.838 0.566     
Current malignant tumor 1.231 3.425 1.408–8.330 0.007 1.322 3.750 1.442–9.751 0.007
Current uarthritis −0.790 0.454 0.102–2.021 0.300     
Laboratory parameters         
Albumin (g/L) −0.038 0.963 0.912–1.016 0.171     
Fast blood glucose (mmol/L) −0.038 1.030 0.933–1.138 0.555     
SCr (μmol/L) −0.003 0.997 0.990–1.005 0.473     
Hcy (μmol/L) 0.014 1.014 0.944–1.090 0.696     
INR −0.184 0.832 0.353–1.960 0.674     
Fibrinogen (g/L) 0.015 1.015 0.875–1.177 0.847     
D-Dimer (mg/L) 0.032 1.033 0.983–1.085 0.200     
CRP (mg/L) 0.004 1.004 0.995–1.012 0.393     
hs-CRP (mg/L) 0.008 1.008 0.997–1.019 0.149     
Initial treatment in hospital         
Anticoagulants 0.374 1.453 0.906–2.331 0.121     
Antiplatelet −0.250 0.779 0.436–1.392 0.399     
Lipid-lowering agents −1.299 1.052 0.288–3.851 0.938     
Thrombolysis −1.258 1.064 0.546–2.071 0.856     
Hormonal treatment −1.300 2.447 0.970–6.172 0.058     
  1. NOTE. CI confidence interval; CRP c-reactive protein; Hcy homocysteine; hs-CRP high-sensitivity C-reactive protein; IDDVT isolated distal deep venous thrombosis; OR odds ratio; SCr serum creatinine concentration